Form 4: Hims & Hers Director Anja Manuel Receives RSU Grant

Hims & Hers Health, Inc. Director Anja Manuel was granted 3,656 Restricted Stock Units, vesting by June 2026.

Summary

• Director Anja Manuel of Hims & Hers Health, Inc. was granted 3,656 Restricted Stock Units (RSUs) on August 6, 2025.
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs will vest subject to continuous service, on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.
• Following this transaction, the reporting person beneficially owns 3,656 Restricted Stock Units.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive sign of continued commitment and aligns the director's interests with long-term shareholder value, reflecting standard corporate governance practices.

Positives

• The grant of Restricted Stock Units aligns the director's interests with long-term shareholder value.
• The equity grant indicates continued commitment of a director to the company's future performance.

Negatives

• No specific negative aspects are identified from this routine Restricted Stock Unit grant.

Risks

• The Restricted Stock Units are subject to forfeiture if continuous service is not maintained until the specified vesting date.

Future Outlook

The granted Restricted Stock Units are scheduled to vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, contingent on continuous service.

Management Comments

• No direct management comments or quotes are provided in this Form 4 filing.

Industry Context

The grant of Restricted Stock Units to a director is a standard practice in corporate governance, aligning executive and director incentives with shareholder interests, common across various industries, including healthcare and technology.

Comparison to Industry Standards

• The grant of Restricted Stock Units is a common form of equity compensation for directors in publicly traded companies, aligning their interests with long-term shareholder value. While the specific number of units granted (3,656) is particular to this individual and company, the mechanism is consistent with compensation practices observed at comparable growth-oriented healthcare technology companies.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are disclosed in this filing.

Related Party Transactions

• The grant of 3,656 Restricted Stock Units to Director Anja Manuel constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's long-term interests with shareholder value, potentially fostering better governance and strategic decisions.

Next Steps

• Vesting of 3,656 Restricted Stock Units on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.

Key Dates

Keywords

Hims & Hers, HIMS, Restricted Stock Units, RSU, Director Compensation, SEC Form 4, Insider Transaction, Anja Manuel, Equity Grant